glp-1 afib Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine GLP‑1 Therapy Improves Atrial Fibrillation

glp-1 afib

glp-1 afib Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine GLP‑1 Therapy Improves Atrial Fibrillation

Name: glp-1 afib Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study | Journal of General Internal Medicine GLP‑1 Therapy Improves Atrial Fibrillation
Brand: trading-ox.com
SKU: 77742040283
Price: 25.59 USD
Availability: InStock
Rating: 4.2709 (29 reviews)

SKU: 77742040283

4.3

EUR25.59 EUR49.59

Pay in 4 interest-free payments of $6.40 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

Description

Assessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system

Research Mechanism In laboratory settings, GHRP-2 is utilized to investigate: GHS-R1a Activation: The binding affinity and signal transduction pathways initiated by ghrelin-mimetic peptides